Launch Broadcast? Yes! Mid Product Life-Cycle? ABSOLUTELY!

One of the most persistent myths about broadcasts is that they are only good for new product launches. The reality is that while product launches are indeed a great time to deploy wide-reaching national broadcasts, their utility extends far beyond this single use.

National broadcasts are perfect for announcing newly approved indications, celebrating approval anniversaries, sharing significant clinical milestones, communicating important study results, rolling out new product messages to HCPs, or even reinvigorating legacy brands with a fresh market perspective later in their lifecycle.

Another scenario to consider: You have just completed your year-beginning meeting (YBM) or annual plan of action (POA) meeting with your entire commercial team and sales force. What’s next?

Broadcasts Offer Reach That is Hard to Match

A broadcast shouldn’t be considered a one-off launch event. They often work best when it becomes an integral part of your annual brand strategy. The core reason for this is that no other single tactic gives you greater reach, generating at least 60-90 minutes of messaging directly from your top speakers. Say you have a single broadcast going out to 40 venues with an average attendance of 20 healthcare professionals. That one broadcast alone equates to 48,000 messaging minutes using a proven peer-to-peer format.

Think about that for a moment. It would take dozens, perhaps even hundreds, of traditional speaker programs to achieve that same reach. The scalability is cost-effective in driving change.

Excellent Cost-Effective Tactic

Whether broadcasting to 20 venues or 200, the incremental cost of adding additional sites is minimal compared to the exponential increase in reach. This makes broadcasts one of the more cost-effective tactics in your medical communications arsenal, especially when you factor in the quality and consistency of the message delivery.

A North Star for Consistency

Speaking of consistency, no other tactic lets you deliver high-quality, consistent content across multiple markets simultaneously. While the reach of a broadcast is hard to match, it is certainly not meant to replace traditional speaker programs or your sales representatives in the field. Rather, the messaging and tone established at a broadcast can act as a North Star for everything that follows.

No matter where they are, everyone gets the same message at the same time, creating consistent brand messaging from top KOLs that’s nearly impossible to achieve through fragmented programs. Everyone gets to hear the same message straight from the top.

For example, when 50 different speakers are delivering 50 different programs across the country, even with the best training, there will be variations in how the message is communicated. Some speakers emphasize certain data points more than others.  A national broadcast eliminates this variability. When reps watch a broadcast featuring your top KOLs, they don’t just learn about the product; they absorb the language, the framing, and the strategic positioning that resonates with physicians. Your carefully crafted messaging, developed with input from medical affairs, legal, regulatory, and commercial teams, is delivered exactly as intended. 

Incorporating Broadcasts Into Your Annual Strategy

When should you schedule broadcasts? Here are some of the most impactful times to consider:

Post-Launch Momentum: Three to six months after launch, once initial uptake has occurred, and you have real-world experience to discuss alongside clinical trial data. This is when physicians are most curious about practical implementation.

New Indications: When new indications are approved, don’t settle for a simple announcement. A broadcast is a proactive and assertive approach to educate on the patient populations, dosing considerations, and competitive positioning in the new space.

New Data Drops: Whenever significant new data is published or presented at major medical conferences. Strike while the data is fresh in people’s minds.

Milestone Approval Anniversaries: The one-year, three-year, or five-year mark of your product’s approval are strategic opportunities to transform your brand from “new and promising” to “established and trusted.”

Clinical Milestones: These moments validate your product’s role in patient care and provide powerful third-party endorsements that resonate with prescribers.

Reinvigorating Legacy Brands: A legacy brand broadcast allows you to reframe your product with fresh perspective. Remind the market that “tried and true” doesn’t mean “old news,” it means proven, reliable, and still relevant.

The bottom line? Take time to regularly ask yourself: How can I integrate broadcasts into my annual strategy to maximize reach, ensure consistency, and keep my organization firing on all cylinders? When you make that shift in thinking, you’ll realize that the best time for a national broadcast isn’t just at launch—it’s whenever your brand needs to make a statement that matters.

Vision2Voice VisionCast

Recent Posts

Globe with Pills

BioPharma in the News – April 2026

The FDA is escalating its ongoing push for transparency and tougher enforcement, including publicizing complete response letters, seeking new authority over DTC drug advertising, and...

Read More
Speaker Standing Next to Broken Clock

When the Universe Has Other Plans: How to Save a Speaker Program in Crisis

It’s the perfect storm: TSA staffing shortages, extreme weather, constant flight delays, and airlines cutting hundreds of flights daily1. There is an in-person speaker program...

Read More
Speakers on a Shelf

Your Speaker’s Bureau Has a Shelf Life: Here’s How to Know When It Needs a Refresh

Nobody wants to be the last one to realize the shelf life of their milk has expired. Yet in biopharma marketing, it happens with speaker’s...

Read More